Are psychedelics superior for treating mental illness? Potentially, yes

Written by Francis Davies, Future Science Group

Psychedelics have displayed greater efficiency for combatting the effects of anxiety and depression over traditional drugs.  

A collaborative study between teams led by Chang Lu at Virginia Tech (VA, USA) and Javier González-Maeso at Virginia Commonwealth University (VA, USA), researchers observed the epigenomic effects of psychedelics. In mice, a single dose of 2,5-dimethoxy-4-iodoamphetamine (DOI), an LSD analogue, demonstrated long-lasting results. Other research, primarily on psilocybin – the active ingredient in 200 species of mushrooms – has also indicated signs of their capability to alleviate anxiety and depression.

READ MORE ON BIOTECHNIQUES NOW